Abstract
DNA interstrand crosslinks (ICLs) are highly toxic lesions associated with cancer and degenerative diseases. ICLs can be repaired by the Fanconi Anemia (FA) pathway and through FA-independent processes involving the FAN1 nuclease. Here, FAN1-DNA crystal structures and biochemical data reveal that human FAN1 cleaves DNA successively at every third nucleotide. In vitro, this exonuclease mechanism allows FAN1 to excise an ICL from one strand through flanking incisions. DNA access requires a 5’-terminal phosphate anchor at a nick or 1–2 nucleotide flap, and is augmented by a 3’ flap, suggesting FAN1 action is coupled to DNA synthesis or recombination. FAN1’s mechanism of ICL excision is well suited for processing other localized DNA adducts as well.
DNA interstrand crosslinks (ICLs) covalently link together the two strands of the double helix (1). ICLs can be repaired by the Fanconi Anemia (FA) pathway of proteins mutated in the FA cancer predisposition syndrome (2), and also by FA-independent processes (1, 3, 4). The FA pathway is activated when a replication fork stalls upon encountering an ICL, leading to unhooking of the ICL through flanking incisions on one strand, translesion DNA synthesis across the unhooked ICL, removal of the ICL remnants by additional incisions, and homologous recombination (2, 5). The FAN1 nuclease (6–9) is a candidate for mediating FA-independent repair (1, 3, 4). While FAN1 mutations result in defective ICL repair, chromosomal instability, and hypersensitivity to a wide range of ICL-inducing agents (6–13), they do not cause FA (10–12). Instead, they cause a kidney degeneration disorder, karyomegalic interstitial nephritis (KIN) (11). FAN1 cleaves branched DNA structures with a preference for 5’ flap substrates, and also exhibits 5’ to 3’ exonuclease activity on a variety of dsDNA and ssDNA substrates (6–9). The functional implications of these broadly-defined activities, whether FAN1 processes ICLs directly and in which manner, and the structural mechanism of ICL unhooking by nucleases are unknown.
To address these questions, we first investigated FAN1’s DNA-binding specificity for various lengths of 5’ flaps consisting of thymidine nucleotides (nts). We found that FAN1 exhibits specificity for a 5’ phosphate group at flap of 1 to 2 nts or at a nick, with dissociation constants (Kd) of 10.3 nM for the 1-nt flap (5’pT1), 121 nM for 2 nts (5’pT2), and 182 nM for the nick (pNi) (fig. S1A). The corresponding substrates lacking the 5’ phosphate group fail to bind appreciably until micromolar FAN1 concentrations (fig. S1A). Similarly, increasing the flap length beyond two nucleotides reduces FAN1 affinity substantially (fig. S1A). We also tested the effect of adding a 3’ flap of 8 thymidine nts to the high-affinity 5’pT1 (5’pT1/3’T8), 5’pT2 (5’pT2/3’T8) and 5’pNi (5’pNi /3’T8), and found that this increased their FAN1 affinity by a factor of ~25 to ~180 (Kd values of 0.4, 1.4, and 1.0 nM, respectively; fig. S1B). By contrast, adding a 3’T8 flap to the low-affinity 5’pT8 (5’pT8/3’T8) minimally enhanced its affinity, with the resulting 377 nM Kd a factor of ~1000 weaker than that of 5’pT1/3’T8 (fig. S1B).
Based on these findings, we determined the 2.9 Å structure of a 5’pG1/3’T4 DNA bound to human FAN1 (residues 364 to 1017), N-terminally truncated to remove the ubiquitin-binding UBZ domain and subsequent unstructured segment, as well as the structure of apo-FAN1 (fig. S2A, and table S1). FAN1 has a bi-lobal structure consisting of a 223-residue N-terminal domain (NTD) and a 415-residue C-terminal domain (CTD) that contains the PD-(D/E)XK nuclease motif (Fig. 1A and B). The DNA adopts a V-shaped structure, with a kink at the nick. The pre-nick and post-nick duplexes have an overall B-DNA conformation, with a 76° angle between them. The pre-nick duplex and 3’ flap are bound by the NTD, while the 5’ flap and post-nick duplex are bound by the CTD. There are no major conformational changes between the apo- and DNA-bound FAN1 structures (fig. S2B).
The NTD consists of a helical domain, a winged-helix (WH) DNA-binding domain, and the predicted SAP domain (Fig. 1C). These form a continuous surface that binds to a 9-bp duplex segment leading to the 3’ flap, and to a 2-nt segment of the flap (Fig. 1A, fig. S3A to C). The duplex contacts involve only phosphodiester groups (fig. S3A to C), except for the flap-proximal base pair, which is contacted at both its phosphodiester and base groups (Fig. 2A). These base contacts block the DNA from extending as a regularly-stacked duplex, analogous to the helix-breaking wedges observed with other structure-specific nucleases (14, 15).
Only the first two nucleotides of the 3’T4 flap are ordered. These extend away from the duplex and are bound by FAN1 (Fig. 2A). The base and ribose groups of the first nucleotide are contacted by Tyr374, Val577 and Arg581. The phosphate group of the second nucleotide binds to a pocket at the amino-terminus of an alpha helix and hydrogen bonds to a backbone amide group (Tyr374) in a partially buried environment. These 3’ flap contacts are consistent with addition of a single-nucleotide 3’ flap to 5’pT1 resulting in roughly half of the affinity increase compared to an 8-nt flap (5’pT1/3’T1 Kd of 1.9 nM, fig. S1B).
The CTD starts with a 180-residue helical repeat domain that belongs to the TPR family, followed by a nuclease domain that has the ~120-residue αβββαβ fold of the PD-(D/E)XK superfamily of Mg2+-dependent nucleases (16, 17) but which additionally contains a 125-residue helical insertion (Fig. 1C). The CTD has a wide and deep groove, with the TPR domain on one side and the nuclease and insertion domains on the other, into which the post-nick duplex binds (Fig. 1B). FAN1 contacts the 5’ phosphate group of the flap and eight phosphodiester groups clustered at the flap-distal portion of the duplex (Fig. 2B). The backbone of the one-nucleotide flap extends orthogonally from the duplex. The 5’ phosphate group abuts a highly basic pocket at the bottom of the CTD groove, with its three non-bridging oxygen atoms hydrogen bonding with the side chains of Arg706, Arg952, His742 and Lys986 (Fig. 2C and D, and fig. S4A). These contacts explain FAN1’s strict requirement for a 5’ phosphate group. Accordingly, the Arg706Ala/Arg952Ala double mutation reduces FAN1’s affinity for 5’pT1/3’T8 by a factor of ~400 (210 nM Kd, fig. S4B). After the 5’ phosphate group, the next two phosphodiester groups make relatively few contacts, while a non-bridging oxygen of the third phosphodiester group coordinates the Ca2+ ion at the nuclease active site (Fig. 2D).
The Ca2+ ion, which does not support nuclease activity (18), has a coordination shell similar to other nucleases (17, 18) (fig. S4C-E). This indicates that cleavage occurs at the third phosphodiester group from the 5’ phosphate (n+3 register) and results in a 5’ phosphorylated product, both of which we confirmed by liquid chromatography-coupled mass spectroscopy (LC-MS) of a nuclease reaction.
In additional co-crystal structures we determined (table S1 and fig. S5A), the 5’ phosphate groups of 5’pT1/3’T8, 5’pT1 and 5’pNi bind to the same FAN1 pocket and contact the same four side chains as in the 5’pG1/3’T4 structure (fig. S5A and C). By contrast, the pocket is devoid of DNA in the co-crystal structure of the 5’-hydroxyl 5’T2, consistent with FAN1’s specificity for a terminal phosphate. The 5’pT1/3’T8, 5’pT1 and 5’pNi structures also suggest some inherent flexibility in the register of the scissile phosphate relative to the 5’ phosphate group. In the 5’pT1/3’T8 and 5’pT1 structures, an extra nucleotide is extruded out in a loop as the 5’ flap backbone transitions to the duplex, resulting in an n+4 scissile phosphate register (fig. S5B and C). And in the 5’pNi structure, a shifted trajectory for the duplex results in an n+2 register (fig. S5C and D).
The importance of a 5’ phosphate group on a short flap/nick is recapitulated in FAN1 nuclease assays. In the presence of 150 mM NaCl and with 100 nM substrate, 5’pT1/3’T8, pNi/3’T8 and 5’pT2/3’T8 are cleaved starting with 0.1 nM FAN1, whereas the longer 5’ flap 5’pT8/3’T8 substrate is not noticeably cleaved even with 100 nM FAN1 (Fig. 3A, fig. S6). 5’pT8/3’T8 cleavage required very low ionic strength, such as the 25 mM NaCl used in previous studies, but its extent was still substantially lower than that of 5’pT1/3’T8 (Fig. 3A, fig S6).
The n+3 scissile phosphate register suggests that FAN1’s reported 5’ to 3’ exonuclease activity results from successive incisions releasing 3-nt fragments. In the time course of a 1 nM stoichiometric FAN1-5’pT1/3’T8 reaction, an 18-nt product corresponding to an n+3 incision appears first, its level peaking at 8 min then declining as it gets consumed (Fig. 3B). A 15-nt product (two n+3 incisions) appears second and peaks at 16–32 min, while a 12-nt product (third incision) appears last. The 5’pNi/3’T8 substrate produces a similar pattern of sequential cuts with a major n+3 spacing (Fig. 3B). Minor products corresponding to n+4 and n+2 incisions likely reflect the alternate scissile phosphate registers of the 5’pT1/3’T8 and 5’pNi co-crystal structures, respectively (fig. S5C).
Successive incisions do not occur in a detectably processive manner (fig. S7A), but meet the criteria of a distributive activity. FAN1 binds to a 3-nt gap substrate (pGap3/3’T8), which corresponds to the first incision product of 5’pNi/3’T8, with a 3.6 nM Kd, compared to 1.0 nM for 5’pNi/3’T8 (fig. S7B), and also cleaves it to generate products equivalent to the second and third products of pNi/3’T8 (Fig. 3C). To determine the effect of increasing gap length, we assayed a 5’pT1/3’T8 substrate containing a long, 35-bp post-nick duplex. The sequential incisions stalled after four cuts even in a 100 nM stoichiometric reaction (fig. S7C), suggesting that a gap length beyond ~12 nts of ssDNA, which presumably loops out at the NTD-CTD interface, substantially reduces FAN1 binding efficiency. In vivo, the stalling could be inconsequential if FAN1 acts at a site with a complementary 3’ flap, or in cooperation with a distributive polymerase, either of which can close the emergent gap and restore high affinity binding.
The n+3 exonuclease mechanism is well suited for unhooking an ICL through two successive incisions flanking it. To test this, we synthesized a stable ICL consisting of two cytosines linked at their N4 positions through a triazole moiety (19) (Fig. 4A, and fig. S8). We first assayed a triazole ICL with the crosslinked cytosine positioned 6 nts after the 5’ phosphorylated nick of a 5’pNi/3’T8 substrate (ICL-6). In a 1 nM stoichiometric reaction, FAN1 robustly cleaved past the ICL, giving rise to post-ICL products that match those of the unmodified control substrate (Crl-6) with similar rates (Fig. 4B and C). We confirmed that this is due to dual incisions 5’ and 3’ to the ICL by LC-MS analysis of the 64 minute reaction, which identified a major molecular species (37 % of the LC-UV quantitation; table S2) consisting of the continuous strand, the triazole linkage and a three nucleotide fragment of Cyt, Gua and Thy (11653.995 and 11653.387 Da observed and calculated mw, respectively; table S2). The ICL-6 products (Fig. 4D) also demonstrate that FAN1 can cleave immediately 5’ to the ICL, with the 5’ phosphodiester group of the crosslinked cytosine at the scissile position.
We next addressed whether FAN1 can unhook the triazole ICL irrespective of its register relative to the 5’ phosphate group. For this, we tested ICLs with the crosslinked cytosine positioned 5, 4 or 3 nts after the 5’ phosphorylated nick (ICL-5, ICL-4 and ICL-3). FAN1 unhooked ICL-4 and ICL-3 at faster rates compared to ICL-6, consistent with this requiring only two incisions compared to three, while the rate of ICL-5 unhooking was intermediate (Fig. 4B to D). LC-MS and denaturing PAGE of the ICL-5 reaction also indicated that FAN1 can cleave immediately 3’ to the ICL (Fig. 4B to D, and table S2).
Diverse ICLs can cause a wide range of DNA-structure distortions, but these are mostly limited to one or two base pairs flanking the lesion (20). The structurally and biochemically observed +/− 1 nt shifts in the scissile phosphate register, coupled to the paucity of FAN1-DNA contacts in the immediate vicinity of the scissile phosphate group, suggest that the FAN1 active site may have substantial flexibility for accommodating such distortions. Our DNA-binding and cleaving data strongly suggests that FAN1 acts at sites that have a 5’ phosphate group on a short flap or nick, possibly generated by an upstream nuclease. Such sites may also arise from the regression of longer 5’ phosphorylated flaps with the concomitant generation of a complementary 3’ flap. If FAN1 accesses the DNA at such a site, it can keep excising with 3’ flap annealing until it reaches the ICL and unhooks it.
Supplementary Material
Acknowledgements
Supported by HHMI (NP and SE) and R01HL120922 (AS). AS is a Rita Allen Foundation Scholar and recipient of a Burroughs Wellcome Career Award and Doris Duke Clinical Scientist Development Award. The PDB accession codes are 4RI8 (5’pG1/3’T4), 4RI9 (5’pT1/3’T8), 4RIA (5’pNi), 4RIB (5’pT1), 4RIC (5’T2) and 4RID (apo-FAN1).
References
- 1.Clauson C, Schärer OD, Niedernhofer L. Cold Spring Harb Perspect Biol. 2013;5:a012732. doi: 10.1101/cshperspect.a012732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kim H, D'Andrea AD. Genes Dev. 2012;26:1393–1408. doi: 10.1101/gad.195248.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Williams HL, Gottesman ME, Gautier J. Trends Biochem. Sci. 2013;38:386–393. doi: 10.1016/j.tibs.2013.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Deans AJ, West SC. Nat. Rev. Cancer. 2011;11:467–480. doi: 10.1038/nrc3088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Long DT, Räschle M, Joukov V, Walter JC. Science. 2011;333:84–87. doi: 10.1126/science.1204258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kratz K, et al. Cell. 2010;142:77–88. doi: 10.1016/j.cell.2010.06.022. [DOI] [PubMed] [Google Scholar]
- 7.Liu T, Ghosal G, Yuan J, Chen J, Huang J. Science. 2010;329:693–696. doi: 10.1126/science.1192656. [DOI] [PubMed] [Google Scholar]
- 8.MacKay C, et al. Cell. 2010;142:65–76. doi: 10.1016/j.cell.2010.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Smogorzewska A, et al. Mol. Cell. 2010;39:36–47. doi: 10.1016/j.molcel.2010.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yoshikiyo K, et al. Proc. Natl. Acad. Sci. U. S. A. 2010;107:21553–21557. doi: 10.1073/pnas.1011081107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhou W, et al. Nat. Genet. 2012;44:910–915. doi: 10.1038/ng.2347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Trujillo JP, et al. Blood. 2012;120:86–89. doi: 10.1182/blood-2012-04-420604. [DOI] [PubMed] [Google Scholar]
- 13.Fontebasso Y, Etheridge TJ, Oliver AW, Murray JM, Carr AM. DNA Repair. 2013;12:1011–1023. doi: 10.1016/j.dnarep.2013.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tsutakawa SE, et al. Cell. 2011;145:198–211. doi: 10.1016/j.cell.2011.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Orans J, et al. Cell. 2011;145:212–223. doi: 10.1016/j.cell.2011.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kinch LN, Ginalski K, Rychlewski L, Grishin NV. Nucleic Acids Res. 2005;33:3598–3605. doi: 10.1093/nar/gki676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pingoud A, Fuxreiter M, Pingoud V, Wende W. Cell. Mol. Life Sci. 2005;62:685–707. doi: 10.1007/s00018-004-4513-1. [DOI] [PubMed] [Google Scholar]
- 18.Hadden JM, Déclais AC, Carr SB, Lilley DM, Phillips SE. Nature. 2007;449:621–624. doi: 10.1038/nature06158. [DOI] [PubMed] [Google Scholar]
- 19.Presolski SI, Hong V, Cho SH, Finn MG. J. Am. Chem. Soc. 2010;132:14570–14576. doi: 10.1021/ja105743g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Muniandy PA, Liu J, Majumdar A, Liu ST, Seidman MM. Crit. Rev. Biochem. Mol. Biol. 2010;45:23–49. doi: 10.3109/10409230903501819. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.